Impact of Surfactants on the Crystallization of Aqueous Suspensions of Celecoxib Amorphous Solid Dispersion Spray Dried Particles

被引:111
|
作者
Chen, Jie [1 ]
Ormes, James D. [2 ]
Higgins, John D. [3 ]
Taylor, Lynne S. [1 ]
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, Coll Pharm, W Lafayette, IN 47907 USA
[2] Merck & Co Inc, Merck Res Labs, Discovery Pharmaceut Sci, Rahway, NJ 07065 USA
[3] Merck & Co Inc, Merck Res Labs, Discovery Pharmaceut Sci, West Point, PA 19486 USA
关键词
spray dried particles; crystallization; surfactants; polymers; SOLUBILITY ADVANTAGE; ENHANCED SOLUBILITY; DISSOLUTION RATE; PHARMACEUTICALS; CARBAMAZEPINE; NANOCRYSTALS; POLYMERS; GROWTH; SYSTEM;
D O I
10.1021/mp5006245
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Amorphous solid dispersions are frequently prepared by spray drying. It is important that the resultant spray dried particles do not crystallize during formulation, storage, and upon administration. The goal of the current study was to evaluate the impact of surfactants on the crystallization of celecoxib amorphous solid dispersions (ASD), suspended in aqueous media. Solid dispersions of celecoxib with hydroxypropylmethylcellulose acetate succinate were manufactured by spray drying, and aqueous suspensions were prepared by adding the particles to acidified media containing various surfactants. Nucleation induction times were evaluated for celecoxib in the presence and absence of surfactants. The impact of the surfactants on drug and polymer leaching from the solid dispersion particles was also evaluated. Sodium dodecyl sulfate and Polysorbate 80 were found to promote crystallization from the ASD suspensions, while other surfactants including sodium taurocholate and Triton X100 were found to inhibit crystallization. The promotion or inhibition of crystallization was found to be related to the impact of the surfactant on the nucleation behavior of celecoxib, as well as the tendency to promote leaching of the drug from the ASD particle into the suspending medium. It was concluded that surfactant choice is critical to avoid failure of amorphous solid dispersions through crystallization of the drug.
引用
收藏
页码:533 / 541
页数:9
相关论文
共 50 条
  • [1] Evaluation of the impact of surfactants on miscibility of griseofulvin in spray dried amorphous solid dispersions
    Bhanderi, Amit
    Bari, Fiza
    Al-Obaidi, Hisham
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 64
  • [2] Impact of surfactants on the crystal growth of amorphous celecoxib
    Mosquera-Giraldo, Laura I.
    Trasi, Niraj S.
    Taylor, Lynne S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 461 (1-2) : 251 - 257
  • [3] REVIEW ON SPRAY DRIED SOLID DISPERSION
    Ashok, Zambre Radhika
    Shendge, R. S.
    Ravindra, Narode Pravin
    Prakash, Sonawane Swapnil
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (03): : 1532 - 1539
  • [4] Application of imaging based tools for the characterisation of hollow spray dried amorphous dispersion particles
    Gamble, John F.
    Ferreira, Ana P.
    Tobyn, Mike
    DiMemmo, Lynn
    Martin, Kyle
    Mathias, Neil
    Schild, Richard
    Vig, Balvinder
    Baumann, John M.
    Parks, Stacy
    Ashton, Mike
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 465 (1-2) : 210 - 217
  • [5] Development and Characterization of Spray-dried Amorphous Solid Dispersion of Sildenafil: In vivo Evaluation
    Ahmed, Mohammed Muqtader
    Fatima, Farhat
    Anwer, Md Khalid
    Aldawsari, Mohammed F.
    Soliman, Gamal A.
    Fayed, Mohamed H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2020, 16 (06) : 460 - 469
  • [6] Crystallization of amorphous components in spray-dried powders
    Chiou, D.
    Langrish, T. A. G.
    [J]. DRYING TECHNOLOGY, 2007, 25 (09) : 1427 - 1435
  • [7] Avoidance of crystallization of hydrophobic drugs in an amorphous solid dispersion during spray-drying and storage
    Yamamoto, Rina
    Imanaka, Hiroyuki
    Ishida, Naoyuki
    Imamura, Koreyoshi
    [J]. DRYING TECHNOLOGY, 2024, : 2022 - 2031
  • [8] Evaluation of Pharmacobezoar Formation from Suspensions of Spray-Dried Amorphous Solid Dispersions: An MRI Study in Rats
    Gierke, Hannes
    Mouchantat, Susan
    Berg, Sabine
    Grimm, Michael
    Hadlich, Stefan
    Kromrey, Marie-Luise
    Nolte, Thomas
    Pfrommer, Teresa
    Roennpagel, Vincent
    Rump, Adrian
    Schaefer, Kerstin
    Willmann, Ann-Cathrin
    Weitschies, Werner
    [J]. PHARMACEUTICS, 2023, 15 (03)
  • [9] Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant
    Leane, Michael M.
    Sinclair, Wayne
    Qian, Feng
    Haddadin, Raja
    Brown, Alan
    Tobyn, Mike
    Dennis, Andrew B.
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (02) : 359 - 366
  • [10] Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel
    Sawicki, Emilia
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Nuijen, Bastiaan
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (02) : 765 - 773